Surgery – Blood drawn and replaced or treated and returned to body – Constituent removed from blood and remainder returned to body
Reexamination Certificate
2006-08-07
2010-12-21
Deak, Leslie R (Department: 3761)
Surgery
Blood drawn and replaced or treated and returned to body
Constituent removed from blood and remainder returned to body
C604S006110, C604S005010, C604S005040, C604S004010, C210S645000, C210S646000
Reexamination Certificate
active
07854718
ABSTRACT:
A dual channel pulsatile pump for use with a completely wearable renal replacement device is provided.
REFERENCES:
patent: 3388803 (1968-06-01), Scott
patent: 3746175 (1973-07-01), Markley
patent: 3884808 (1975-05-01), Scott
patent: 3989622 (1976-11-01), Marantz et al.
patent: 3994799 (1976-11-01), Yao et al.
patent: 4094775 (1978-06-01), Mueller
patent: 4212738 (1980-07-01), Henne
patent: 4247393 (1981-01-01), Wallace
patent: 4267040 (1981-05-01), Schal
patent: 4269708 (1981-05-01), Bonomini et al.
patent: 4326955 (1982-04-01), Babb et al.
patent: 4443333 (1984-04-01), Mahurkar
patent: 4765907 (1988-08-01), Scott
patent: 4897189 (1990-01-01), Greenwood et al.
patent: 4997570 (1991-03-01), Polaschegg
patent: 5284470 (1994-02-01), Beltz
patent: 5415532 (1995-05-01), Loughnane et al.
patent: 5577891 (1996-11-01), Loughnane et al.
patent: 5672268 (1997-09-01), Mizrahi et al.
patent: 5902336 (1999-05-01), Mishkin
patent: 5944684 (1999-08-01), Roberts et al.
patent: 5980481 (1999-11-01), Gorsuch
patent: 5984891 (1999-11-01), Keilman et al.
patent: 6117100 (2000-09-01), Powers et al.
patent: 6117122 (2000-09-01), Din et al.
patent: 6196922 (2001-03-01), Hantschk et al.
patent: 6406631 (2002-06-01), Collins et al.
patent: 6610036 (2003-08-01), Branch et al.
patent: 6796955 (2004-09-01), O'Mahony et al.
Shettigar, et al, “A portable hemodialysis/hemofiltration system independent of dialysate and infusion fluid.” Artif Organs, vol. 7, No. 2, May 1983, pp. 254-256.
Manns, Markus et al, “The acu-men: A New Device for Continuous Renal Replacement Therapy in Acute Renal Failure,” Kidney International, vol. 54, 1998, pp. 268-274.
Lockridge, R.S. Jr., “The Direction of End-Stage Renal Disease Reimbursement in the United States,” Semin Dial, vol. 17, 2004, pp. 125-130.
Lockridge, R.S. Jr., et al, “Is HCFA's Reimbursement Policy Controlling Quality of Care for End-State Renal Disease Patients?” ASAIO J, vol. 47, 2001, pp. 466-468.
Manns, B.J. et al, “Dialysis Adequacy and Health Related Quality of Life in Hemodialysis Patients,” ASAIO J, vol. 48, 2002, pp. 565-569.
Mapes, D.L. et al, “Health-related Quality of Life as a Predictor of Mortality and Hospitalization: The Dialysis Outcomes and Practice Patterns Study (DOPPS),” Kidney Int., vol. 64, 2003, pp. 339-349.
McFarlane, P.A. et al, “The Quality of Life and Cost Utility of Home Nocturnal and Conventional In-center Hemodialysis,” Kidney Int., vol. 64, 2003, pp. 1004-1011.
Mohr, P. E., et al, “The Case for Daily Dialysis: Its Impact on Costs and Quality of Life,” Am J Kidney Dis., vol. 37, 2001, pp. 777-789.
Patel, S. S., et al, “Psychosocial Variables, Quality of Life, and Religious Beliefs in ESRD Patients Treated with Hemodialysis,” Am J Kidney Dis., vol. 40, 2002, pp. 1013-1022.
“Sorbent Dialysis Primer,” Organon Teknika Corp., 1991.
Ronco, C., et al, “Blood and Dialysate Flow Distribution in Hollow-fiber Hemodialyzers Analyzed by Computerized Helical Scanning Technique,” J Am Soc Nephrol, vol 13, 2002, pp. S53-S61.
Mineshima, M., et al, “Effects of Internal Filtration on the Solute Removal Efficiency of a Dialyzer.” ASAIO J, vol. 46, 2000, pp. 456-460.
Ronco, C., et al, “The Hemodialysis System: Basic Mechanisms of Water And Solute Transport in Extracorporeal Renal Replacement Therapies,” Nephrol Dial Transplant, vol. 13 Suppl. 6, 1998, pp. 3-9.
Miwa, M. et al, “Push/Pull Hemodiafiltration: Technical Aspects and Clinical Effectiveness,” Artif Organs, vol. 23, 1999, pp. 1123-1128.
Runge, T.M., et al, “Hemodialysis: Evidence of Enhanced Molecular Clearance and Ultrafiltration Volume By Using Pulsatile Flow,” Int J Artif Organs, vol. 16, 1993, pp. 645-652.
Ding, L. H., et al, “Dynamic filtration of Blood: A New Concept for Enhancing Plasma Filtration,” Int J Artif Organs, vol. 14, 1991, pp. 365-370.
Bird, R. B., et al, Transport Phenomena, Wiley, New York, 1976, pp. 126-130, 502-531, 558-563, 624-625, 700-711.
Welty, J. R., et al, “Chapter 27: Unsteady-state Molecular Diffusion,” Fundamentals of Momentum, Heat, and Mass Transfer (2nd ed.), McGraw-Hill, New York, 1984.
Siaghy, E. M., et al, “Consequences of Static and Pulsatile on Transmembrane Exchanges During Vitro Microdialysis: Implication for Studies in Cardiac Physiology,” Med Biol Eng Comput, vol. 37, 1999, pp. 196-201.
Utsunomiya, T., et al, “Effect of Direct Pulsatile Peritoneal Dialysis on Peritoneal Permeability and Lymphatic Absorption in the Rat,” Nippon Jinzo Gakkai Shi, vol. 37, 1995, pp. 24-28.
Jaffrin, M. Y., et al, “Rationale of Filtration Enhancement in Membrane Plasmapheresis by Pulsatile Blood Flow,” Life Support Systems, vol. 5, 1987, pp. 267-271.
Kobayashi, E., “A Study of Inorganic Ion Exchangers VII; The Synthesis of gammaNH4ZrH(PO4)2 and Ion-Exchange Properties of gamma-NH4Zr(HPO4)2.2H20,” Bull Chem Soc Jpn, vol. 56, 1983, pp. 3756-3760.
Suri, R, et al, “Adequacy of Quotidian Hemodialysis,” Am J Kidney Dis, vol. 42 Suppl. 1, 2003, pp. S42-S48.
Gotch, F. A., “The Current Place of Urea Kinetic Modelling with Respect to Different Dialysis Modalities,” Nephrol Dial Transplant, vol. 13 Suppl. 6, 1998, pp. 10-14.
Gotch, F. A., et al, “Effective Diffusion Volume Flow Rates (Qe) for Urea, Creatinine, and Inorganic Phosphorous (Qeu, Qecr, QeiP) During Hemodialysis,” Semin Dial, vol. 16, 2003, pp. 474-476.
Roberts, Martin, “Wearable Artificial Kidneys for Continuous Dialysis,” ASAIO Journal, 1993, pp. 19-23.
Murisasco, A., et al, “Continuous Arterio-venous Hemofiltration in a Wearable Device to Treat End-stage Renal Disease,” Trans Am Soc Artif Intern Organs, 1986, vol. XXXII, pp. 567-571.
Murisasco, A., et al, “A Continuous Hemofiltration System Using Sorbents for Hemofiltrate Regeneration,” Clinical Nephrology, 1986, pp. S53-S57, vol. 26, Supp. No. 1.
Lande', Arnold J., et al, “In Search of a 24 Hours Per Day Artificial Kidney,” Journal of Dialysis, 1(8), 1977, pp. 805-823.
Gura, V., et al, “CRRT for ESRD: The Wearable Artificial Kidney: A Feasible, Safe, and Cost Effective Way to Provide Daily Dialysis,” J Am Soc Nephrol, vol. 15, 2004, p. 639A.
Gura Victor
Rambod Edmond
Deak Leslie R
Fresenius Medical Care Holdings, Inc.
Hamilton Brook Smith & Reynolds P.C.
LandOfFree
Dual-ventricle pump cartridge, pump and method of use in a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dual-ventricle pump cartridge, pump and method of use in a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dual-ventricle pump cartridge, pump and method of use in a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4191110